product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Quantikine Immunoassay Control Set 1063 for Human tPA
catalog :
QC207
quantity :
1 Each
price :
170 USD
more info or order :
product information
master code :
QC207
SKU :
QC207
product name :
Quantikine Immunoassay Control Set 1063 for Human tPA
unit size :
1 Each
description :
The Quantikine Immunoassay Control Set 1063 for Human tPA from R&D Systems quantifies human t-Plasminogen Activator/tPA.
target :
t-Plasminogen Activator/tPA
category :
ELISAs
species :
Human
gene symbol :
PLAT
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=elisas
applications :
Control
extended description :
For use with catalog number DTPA00
USD :
170 USD
product details :
For use with catalog number DTPA00
alt names :
Alteplase, DKFZp686I03148, EC 3.4.21, EC 3.4.21.68, plasminogen activator, tissue, plasminogen activator, tissue type, PLAT, reteplase, tissue plasminogen activator (t-PA), tissue-type plasminogen activator, TPA, T-PA, t-plasminogen activator, tPlasminogen Activator
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Quantikine Immunoassay Control Set 1178 for Human COMP | QC66
- Quantikine Immunoassay Control Group 239 for Human VEGFR1 | QC239
- Quantikine Immunoassay Control Set 637 for Human Total MMP-3 | QC127
- Quantikine Immunoassay Control Set 778 Human Serpin E1/PAI-1 | QC157
- Human Magnetic Luminex® Performance Assay Base Kit, Biomarker Panel A
questions and comments